| Diabetic nephropathy: diagnosis, prevention, and treatment JL Gross, MJ De Azevedo, SP Silveiro, LH Canani, ML Caramori, ... Diabetes care 28 (1), 164-176, 2005 | 2674 | 2005 |
| Sotagliflozin in patients with diabetes and chronic kidney disease DL Bhatt, M Szarek, B Pitt, CP Cannon, LA Leiter, DK McGuire, JB Lewis, ... New England Journal of Medicine 384 (2), 129-139, 2021 | 914 | 2021 |
| Oral semaglutide versus empagliflozin in patients with type 2 diabetes uncontrolled on metformin: the PIONEER 2 trial HW Rodbard, J Rosenstock, LH Canani, C Deerochanawong, ... Diabetes care 42 (12), 2272-2281, 2019 | 354 | 2019 |
| Genome-wide association scan for diabetic nephropathy susceptibility genes in type 1 diabetes MG Pezzolesi, GD Poznik, JC Mychaleckyj, AD Paterson, MT Barati, ... Diabetes 58 (6), 1403-1410, 2009 | 343 | 2009 |
| Diabetic retinopathy predicts all-cause mortality and cardiovascular events in both type 1 and 2 diabetes: meta-analysis of observational studies CK Kramer, TC Rodrigues, LH Canani, JL Gross, MJ Azevedo Diabetes care 34 (5), 1238-1244, 2011 | 278 | 2011 |
| Aggregation of features of the metabolic syndrome is associated with increased prevalence of chronic complications in Type 2 diabetes LA Costa, LH Canani, HRK Lisboa, GS Tres, JL Gross Diabetic Medicine 21 (3), 252-255, 2004 | 274 | 2004 |
| The type 2 deiodinase A/G (Thr92Ala) polymorphism is associated with decreased enzyme velocity and increased insulin resistance in patients with type 2 diabetes mellitus LH Canani, C Capp, JM Dora, ELS Meyer, MS Wagner, JW Harney, ... The Journal of Clinical Endocrinology & Metabolism 90 (6), 3472-3478, 2005 | 234 | 2005 |
| Coronary artery calcium score prediction of all cause mortality and cardiovascular events in people with type 2 diabetes: systematic review and meta-analysis CK Kramer, B Zinman, JL Gross, LH Canani, TC Rodrigues, MJ Azevedo, ... Bmj 346, 2013 | 188 | 2013 |
| The role of the uncoupling protein 1 (UCP1) on the development of obesity and type 2 diabetes mellitus LA Brondani, TS Assmann, GCK Duarte, JL Gross, LH Canani, D Crispim Arquivos Brasileiros de Endocrinologia & Metabologia 56, 215-225, 2012 | 179 | 2012 |
| Familial clustering of diabetic nephropathy in Brazilian type 2 diabetic patients. LH Canani, F Gerchman, JL Gross Diabetes 48 (4), 909-913, 1999 | 157 | 1999 |
| Efficacy and safety of topiramate on weight loss: a meta‐analysis of randomized controlled trials CK Kramer, CB Leitao, LC Pinto, LH Canani, MJ Azevedo, JL Gross Obesity reviews 12 (5), e338-e347, 2011 | 155 | 2011 |
| Masked hypertension, urinary albumin excretion rate, and echocardiographic parameters in putatively normotensive type 2 diabetic patients CB Leitao, LH Canani, CK Kramer, JC Boza, AF Pinotti, JL Gross Diabetes care 30 (5), 1255-1260, 2007 | 152 | 2007 |
| Prevalência de complicações micro e macrovasculares e de seus fatores de risco em pacientes com diabetes melito do tipo 2 em atendimento ambulatorial RS Scheffel, D Bortolanza, CS Weber, LA Costa, LH Canani, KG Santos, ... Revista da Associação Médica Brasileira 50, 263-267, 2004 | 151 | 2004 |
| Meta-Analysis Reveals the Association of Common Variants in the Uncoupling Protein (UCP) 1–3 Genes with Body Mass Index Variability LA Brondani, TS Assmann, BM de Souza, AP Boucas, LH Canani, ... PloS one 9 (5), e96411, 2014 | 140 | 2014 |
| Nitric oxide system and diabetic nephropathy BS Dellamea, CB Leitão, R Friedman, LH Canani Diabetology & metabolic syndrome 6, 1-6, 2014 | 135 | 2014 |
| Clinical and laboratory profile of patients with type 2 diabetes with low glomerular filtration rate and normoalbuminuria CK Kramer, CB Leitão, LC Pinto, SP Silveiro, JL Gross, LH Canani Diabetes care 30 (8), 1998-2000, 2007 | 135 | 2007 |
| A genome-wide linkage scan for genes controlling variation in urinary albumin excretion in type II diabetes AS Krolewski, GD Poznik, G Placha, L Canani, J Dunn, W Walker, ... Kidney international 69 (1), 129-136, 2006 | 131 | 2006 |
| The role of uncoupling protein 2 (UCP2) on the development of type 2 diabetes mellitus and its chronic complications BM Souza, TS Assmann, LM Kliemann, JL Gross, LH Canani, D Crispim Arquivos Brasileiros de Endocrinologia & Metabologia 55, 239-248, 2011 | 129 | 2011 |
| Nitric oxide levels in patients with diabetes mellitus: A systematic review and meta-analysis TS Assmann, LA Brondani, AP Boucas, J Rheinheimer, BM de Souza, ... Nitric Oxide 61, 1-9, 2016 | 126 | 2016 |
| The human peroxisome proliferator-activated receptor γ2 (PPARγ2) Pro12Ala polymorphism is associated with decreased risk of diabetic nephropathy in patients with type 2 diabetes ML Caramori, LH Canani, LA Costa, JL Gross Diabetes 52 (12), 3010-3013, 2003 | 116 | 2003 |
Daisy CrispimEndocrinologia/ Hospital de Clinicas de Porto Alegre/ Universidade Federal do Rio Grande do Sul在 hcpa.edu.br 的电子邮件经过验证
